{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T15:29:17Z","timestamp":1764084557357,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.pcd.2014.10.009","type":"journal-article","created":{"date-parts":[[2014,11,24]],"date-time":"2014-11-24T13:16:31Z","timestamp":1416834991000},"page":"261-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Primary care screening for individuals with impaired glucose metabolism with focus on impaired glucose tolerance"],"prefix":"10.1016","volume":"9","author":[{"given":"Margareta I.","family":"Hellgren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bledar","family":"Daka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per-Anders","family":"Jansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Lindblad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.pcd.2014.10.009_bib0005","doi-asserted-by":"crossref","first-page":"e52036","DOI":"10.1371\/journal.pone.0052036","article-title":"Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis","volume":"7","author":"Gast","year":"2012","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.pcd.2014.10.009_bib0010","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.pcd.2014.10.009_bib0015","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.pcd.2014.10.009_bib0020","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1007\/s00125-009-1443-3","article-title":"Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?","volume":"52","author":"Faerch","year":"2009","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.pcd.2014.10.009_bib0025","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.2337\/dc06-2466","article-title":"Recruiting high-risk individuals to a diabetes prevention program: how hard can it be?","volume":"30","author":"Ruge","year":"2007","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.pcd.2014.10.009_bib0030","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.2337\/dc09-1957","article-title":"Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic U.S. adults","volume":"33","author":"Karve","year":"2010","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.pcd.2014.10.009_bib0035","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2337\/diacare.28.7.1786","article-title":"Changing the definition of impaired fasting glucose: impact on the classification of individuals and risk definition","volume":"28","author":"Vaccaro","year":"2005","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.pcd.2014.10.009_bib0040","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-0028-1087203","article-title":"Tools for predicting the risk of type 2 diabetes in daily practice","volume":"41","author":"Schwarz","year":"2009","journal-title":"Horm. Metab. Res."},{"issue":"9","key":"10.1016\/j.pcd.2014.10.009_bib0045","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1055\/s-2007-985353","article-title":"A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population","volume":"39","author":"Bergmann","year":"2007","journal-title":"Horm. Metab. Res."},{"issue":"1","key":"10.1016\/j.pcd.2014.10.009_bib0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.diabres.2010.12.020","article-title":"Evaluation of the Finnish diabetes risk score as a screening tool for impaired fasting glucose: impaired glucose tolerance and undetected diabetes","volume":"92","author":"Tankova","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"2","key":"10.1016\/j.pcd.2014.10.009_bib0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1055\/s-0028-1087191","article-title":"A more simplified Finnish diabetes risk score for opportunistic screening of undiagnosed type 2 diabetes in a German population with a family history of the metabolic syndrome","volume":"41","author":"Li","year":"2009","journal-title":"Horm. Metab. Res."},{"issue":"2","key":"10.1016\/j.pcd.2014.10.009_bib0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3132\/dvdr.2005.011","article-title":"Cross-sectional evaluation of the Finnish diabetes risk score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome","volume":"2","author":"Saaristo","year":"2005","journal-title":"Diabetes Vasc. Dis. Res."},{"issue":"3","key":"10.1016\/j.pcd.2014.10.009_bib0065","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1210\/jc.2007-2427","article-title":"The Finnish diabetes risk score is associated with insulin resistance and progression towards type 2 diabetes","volume":"94","author":"Schwarz","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.pcd.2014.10.009_bib0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.diabres.2010.06.008","article-title":"The potential impact and optimal cut-points of using glycated haemoglobin, HbA1c, to detect people with impaired glucose regulation in a UK multi-ethnic cohort","volume":"90","author":"Mostafa","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"5","key":"10.1016\/j.pcd.2014.10.009_bib0075","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2337\/diacare.28.5.1187","article-title":"Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study","volume":"28","author":"Franciosi","year":"2005","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.pcd.2014.10.009_bib0080","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2337\/diacare.27.3.727","article-title":"A Danish diabetes risk score for targeted screening: the Inter99 study","volume":"27","author":"Glumer","year":"2004","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.pcd.2014.10.009_bib0085","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/dc06-2089","article-title":"An accurate risk score based on anthropometric: dietary, and lifestyle factors to predict the development of type 2 diabetes","volume":"30","author":"Schulze","year":"2007","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.pcd.2014.10.009_bib0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2337\/diacare.22.2.213","article-title":"Performance of a predictive model to identify undiagnosed diabetes in a health care setting","volume":"22","author":"Baan","year":"1999","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.pcd.2014.10.009_bib0175","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5694\/j.1326-5377.2010.tb03478.x","article-title":"AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures","volume":"192","author":"Chen","year":"2010","journal-title":"Med J Aust"},{"issue":"5","key":"10.1016\/j.pcd.2014.10.009_bib0100","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s11606-008-0524-1","article-title":"Random plasma glucose in serendipitous screening for glucose intolerance: screening for impaired glucose tolerance study 2","volume":"23","author":"Ziemer","year":"2008","journal-title":"J. Gen. Intern. Med."},{"issue":"4","key":"10.1016\/j.pcd.2014.10.009_bib0105","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2337\/dc08-0403","article-title":"Random capillary blood glucose cut points for diabetes and pre-diabetes derived from community-based opportunistic screening in India","volume":"32","author":"Somannavar","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2014.10.009_bib0110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1472-6823-9-16","article-title":"Salivary cortisol differs with age and sex and shows inverse associations with WHR in Swedish women: a cross-sectional study","volume":"9","author":"Larsson","year":"2009","journal-title":"BMC Endocr. Dis."},{"issue":"1","key":"10.1016\/j.pcd.2014.10.009_bib0115","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.2337\/dc12-s064","article-title":"Diagnosis and classification of diabetes mellitus","volume":"35","author":"American Diabetes Association","year":"2012","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.pcd.2014.10.009_bib0120","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2337\/dc09-9033","article-title":"Expert Committee report on the role of the A1C assay in the diagnosis of diabetes","volume":"32","author":"International","year":"2009","journal-title":"Diabetes Care"},{"journal-title":"Diabetolognytt","article-title":"HbA1c inf\u00f6rs som komplement till diagnostik p\u00e5 v\u00e5rdcentraler fr\u00e5n 1 jan 2014\u2014en del klarl\u00e4ggande","year":"2013","key":"10.1016\/j.pcd.2014.10.009_bib0125"},{"issue":"10","key":"10.1016\/j.pcd.2014.10.009_bib0130","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s10654-011-9619-9","article-title":"Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening","volume":"26","author":"Schottker","year":"2011","journal-title":"Eur. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.pcd.2014.10.009_bib0135","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00592-011-0334-5","article-title":"Assessment of HbA1c as a diagnostic tool in diabetes and prediabetes","volume":"49","author":"Tankova","year":"2012","journal-title":"Acta Diabetol."},{"issue":"7","key":"10.1016\/j.pcd.2014.10.009_bib0140","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.numecd.2011.04.009","article-title":"Comparison of A1C, fasting and 2-h post-load plasma glucose criteria to diagnose diabetes in Italian Caucasians","volume":"22","author":"Marini","year":"2012","journal-title":"Nutr., Metab. Cardiovasc. Dis.: NMCD"},{"issue":"5","key":"10.1016\/j.pcd.2014.10.009_bib0145","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1089\/met.2013.0128","article-title":"Use of HbA1c for diagnoses of diabetes and prediabetes: comparison with diagnoses based on fasting and 2-Hr glucose values and effects of gender, race, and age","volume":"12","author":"Guo","year":"2014","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"8","key":"10.1016\/j.pcd.2014.10.009_bib0150","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00392-012-0435-3","article-title":"Comparison of HbA1c and oral glucose tolerance test for diagnosis of diabetes in patients with coronary artery disease","volume":"101","author":"Farhan","year":"2012","journal-title":"Clin. Res. Cardiol."},{"issue":"1","key":"10.1016\/j.pcd.2014.10.009_bib0155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2337\/dc09-1227","article-title":"ison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults","volume":"33","author":"Carson","year":"2010","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.pcd.2014.10.009_bib0160","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2796.2006.01689.x","article-title":"A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed","volume":"260","author":"Norberg","year":"2006","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.pcd.2014.10.009_bib0165","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.diabres.2012.03.009","article-title":"A comparison of cost per case detected of screening strategies for Type 2 diabetes and impaired glucose regulation: modelling study","volume":"97","author":"Khunti","year":"2012","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.pcd.2014.10.009_bib0170","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/epirev\/mxq019","article-title":"Risk assessment tools for identifying individuals at risk of developing type 2 diabetes","volume":"33","author":"Buijsse","year":"2011","journal-title":"Epidemiol. Rev."}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991814001284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991814001284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:54:53Z","timestamp":1761695693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751991814001284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1751991814001284"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2014.10.009","relation":{},"ISSN":["1751-9918"],"issn-type":[{"type":"print","value":"1751-9918"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary care screening for individuals with impaired glucose metabolism with focus on impaired glucose tolerance","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2014.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}